SCHEMBL8499476

SCHEMBL8499476

c1ccc2ncc(-c3csc4ccccc34)cc2c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDGFRB P09619 3/20 0.54
PDGFRA P16234 3/20 0.54
TOP2A P11388 1/20 0.46
TOP2B Q02880 1/20 0.46
CYP2A6 P11509 1/20 0.45
BIRC5 O15392 1/20 0.44
PIK3CD O00329 2/20 0.43
PIK3CA P42336 2/20 0.43
PTK2 Q05397 1/20 0.42
ERN1 O75460 1/20 0.42
HTR1A P08908 1/20 0.42
NISCH Q9Y2I1 1/20 0.41
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA9 Q16790 1/20 0.41
GRM4 Q14833 1/20 0.41
PIM1 P11309 2/20 0.41
PIM3 Q86V86 2/20 0.41
PIM2 Q9P1W9 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14365350 0.77 CDK8 (0.56) PDGFRBPDGFRAPIK3CDPIK3CAPIK3CB
SCHEMBL1682843 0.76 PTK2 (0.50) PDGFRBPDGFRATOP2ATOP2BCYP2A6
SCHEMBL30547072 0.76 PDGFRB (0.60) PDGFRBPDGFRATOP2ATOP2BCYP2A6
SCHEMBL2198777 0.76 PDGFRB (0.60) PDGFRBPDGFRATOP2ATOP2BCYP2A6
SCHEMBL32667946 0.74 PDGFRB (0.77) PDGFRBPDGFRATOP2ATOP2BCYP2A6
SCHEMBL2772360 0.74 PDGFRB (0.77) PDGFRBPDGFRATOP2ATOP2BCYP2A6
SCHEMBL17067721 0.74 ERN1 (0.40) ERN1TGFBR1KDM1A
SCHEMBL31428879 0.73 PDGFRB (0.57) PDGFRBPDGFRATOP2ATOP2BCYP2A6
SCHEMBL20873052 0.73 PDGFRB (0.57) PDGFRBPDGFRATOP2ATOP2BCYP2A6
SCHEMBL20873082 0.73 PDGFRB (0.57) PDGFRBPDGFRATOP2ATOP2BCYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE36256-E ADMINISTERING ARYL-SUBSTITUTED QUINOXALINE DERIVATIVES AS ANTIPROLIFERATIVE, ANTICARCINOGENIC AND ANTITUMOR AGENTS RHONE-POULENC RORER PHARMACEUTICALS, INC. (US) 1999-07-20 US disclosed
US-5795889-A INHIBITING CELL GROWTH WITH ENZYME INHIBITORS FOR SKIN DISORDERS RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1998-08-18 US disclosed
EP-0584222-B1 BIS MONO-AND BICYCLIC ARYL AND HETEROARYL COMPOUNDS WHICH INHIBIT EGF AND/OR PDGF RECEPTOR TYROSINE KINASE RHONE POULENC RORER INT (US) 1997-10-08 EP disclosed
US-5656643-A QUINOLIN PYRIDINE DERIVATIVES; USEFUL FOR TREATING CANCER, LEKEMIA, PSORIASIS, INFLAMMATORY DISODERS, BONE DISORDERS, ATHEROSCLEROSIS AND RESTENOSIS; CONTROLLS CELLULAR REPRODUCTION RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1997-08-12 US disclosed
US-5646153-A INHIBITING ABNORMAL CELL PROLIFERATION RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1997-07-08 US disclosed
US-5480883-A Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1996-01-02 US disclosed
US-5409930-A Inhibits abnoramal cell proliferation; dimethoxyquinoline/ dimethylquinoline/ quinolineoxide/ and quinoxaline derivatives RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1995-04-25 US disclosed
EP-0584222-A4 BIS MONO-AND BICYCLIC ARYL AND HETEROARYL COMPOUNDS WHICH INHIBIT EGF AND/OR PDGF RECEPTOR TYROSINE KINASE RHONE POULENC RORER INT (US) 1994-07-06 EP disclosed
EP-0584222-A1 BIS MONO-AND BICYCLIC ARYL AND HETEROARYL COMPOUNDS WHICH INHIBIT EGF AND/OR PDGF RECEPTOR TYROSINE KINASE. RHONE POULENC RORER INT (US) 1994-03-02 EP disclosed
WO-1992020642-A1 BIS MONO-AND BICYCLIC ARYL AND HETEROARYL COMPOUNDS WHICH INHIBIT EGF AND/OR PDGF RECEPTOR TYROSINE KINASE RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) 1992-11-26 WO disclosed